Schistosomiasis: Progress and problems

World Journal of Gastroenterology

Volumn 6, Issue 1, 2000, Pages 12-19

  Wu, G Y ^a   Halim, M H ^b  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b NATIONAL RESEARCH CENTRE   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

METRIFONATE; OXAMNIQUINE; PRAZIQUANTEL;

BLADDER CANCER; COLIC; DERMATITIS; DIARRHEA; DISEASE ASSOCIATION; DRUG EFFECT; DRUG TOLERANCE; GASTROINTESTINAL SYMPTOM; HEPATOSPLENOMEGALY; HUMAN; IMMUNOLOGY; KATAYAMA DISEASE; LIVER CIRRHOSIS; LUNG DISEASE; MUSCLE FATIGUE; NAUSEA; PORTAL HYPERTENSION; REVIEW; SCHISTOSOMA HEMATOBIUM; SCHISTOSOMA JAPONICUM; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; UROGENITAL TRACT DISEASE; VOMITING;

EID: 0033973034     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v6.i1.12     Document Type: Review

References (79)

1. Waine GJ, McManus DP. Schistosomiasis vaccine development-the current picture. Bioessays, 1997;5:435-443
2. El-Khoby T, Galal N, Fenwick A. The USAID/Government of Egypt 's Schistosomiasis Research Project (SRP). Parasitol Today, 1998; 14:92-96
3. WHO. The control of schistosomiasis. First report of a WHO expert committee. World Health Organization, Genava, Tech Rep, 1985; 728:1-113
4. Warren KS. Schistosomiasis, Host-Pathogen Biology. Reviews of Infectious Diseases, 1982;4:771-775
5. Mason (1903), Cited by Wilcoks C. Aspects of Medical Investigations in Africa. 1962:28-54
6. Sambon (1907), Cited by Wilcoks C. Aspects of Medical Investigation in Africa. 1962:28-54
7. Leiper RT. Report on the results of the bilharzia mission in Egypt-I. Transmission. J. R. Arm. Medical Corps, 1915;25:1-55
8. Scott JA. Dilution egg counting in comparison with other methods for determining the incidence of schistosoma mansoni. Am J Hyg, 1937; 25:546
9. Abdel-Wahab MF, Strickland GT, El-Sahly GT, Ahmed L, Zakaria S, El-Kady N, Mahmoud S. Schistosomiasis mansoni in an Egyptian village in the Nile Delta. Am J Trop Med Hyg, 1980;29:868-874
10. Weinstock JV. The pathogenesis of granulomatous inflammation and organ injury in schistosomiasis: interactions between the schistosome ova and the host. Immunol Invest, 1992;21:455-475
11. Basch PF. Cultivation of schistosoma mansoni in vitro. II. Production of infertile eggs by the worm pairs cultured from cercariae. J Parasitol, 1981;67:186-190
12. Tiba Y, Holanda JC, Ramalho-Pinto FJ, Gazzinelli G, Pellegrino J. Letter; Schistosomula (Schistosoma mansoni) obtained in vitro; viability in culture and infectivity for mice. Trans R Soc Trop Med Hyg, 1974;68:72
13. Basch PF, Humbert R. Cultivation of Schistosoma mansoni in vitro. III. Implantation of cultured worms into mouse mesenteric veins. J Parasitol, 1981;67:191-195
14. Clemens LE, Basch PF. Schistosoma mansoni: effect of transferrin and growth factors on development of schistosomula in vitro. J Parasitol, 1989;75:417-421
15. Robinson DLH. Egg laying by S. mansoni in vitro. Ann Trop Med Parasitol, 1960;54:112-117
16. Wu GY, Wu CH. Portal serum constituents: possible determinants for anatomical localization of Schistosoma during maturation and reproduction. J Chemical Ecology, 1986;12:1797-1803
17. Hobbs DJ, Fryer SE, Duimstra JR, Hedstrom OD, Brodie AM, Collodi PM, Menino JS, Bayne CJ, Barnes DW. Culture of cells from juvenile worms of schistosoma mansoni. J Parasitol, 1993;79:913-921
18. Taylor MG, Amin MB, Nelson GS. "Parthenogenesis" in Schistosoma mattheei. J Helminthol, 1969;43:197-206
19. Taylor MG. Further observations on the sexual maturation of female schistosomes in single-sex infections. J Helminthol, 1971;45:89-92
20. Ishikawa E. The regulation of uptake and output of amino acids by rat tissues. Adv Enzyme Regul, 1976;14:117-136
21. Wu GY, Wu CH, Dunn MA, Kamel R. Stimulation of S. mansoni oviposition in vitro by animal and human portal serum. Am J Trop Med Hyg, 1985;34:750-753
22. Shaker YM, Wu CH, El-Shobaki FA, Ashour E, Khattab HM, Draz HM, Kamel R, Wu GY. Human portal serum stimulates cell proliferation in immature S. mansoni. Parasitology, 1998;117(Pt 4):293-299
23. Hang LM, Warren KS, Boros DL. Schistosoma mansoni: antigenic secretions and the etiology of egg granulomas in mice. Exp Parasitol, 1974;35:288-298
24. Harn DA, Danko K, Quinn JJ, Stadecker MJ. Schistosoma mansoni: the host immune response to egg antigens. I. Partial characterization of cellular and humoral responses to pI fractions of soluble egg antigen. J Immunol, 1989;142:2061-2066
25. Lukacs NW, Boros DL. Identification of larval cross-reactive and egg-specific antigens involved granuloma formation in murine schistosomiasis mansoni. Infect Immun, 1991;59:3237-3242
26. Capron A, Dessaint JP, Capron M, Joseph M, Pestel J. Role of anaphylactic antibodies in immunity to schistosomes. Am J Trop Med Hyg, 1980;29:849-857
27. Boyer MH, Kalfayan LJ, Ketchum DG. The host antigen phenomenon in experimental murine schistosomiasis. III. Destruction of parasites transferred from mice to hamsters. Am J Trop Med Hyg, 1977;26-254-257
28. Torpier G, Capron A, Ouaissi MA. Receptor for IgG (Fc) and human beta2-microglobulin on S. mansoni schistosomula. Nature, 1979; 278:447-449
29. Damian RT, Greene ND, Hubbard WJ. Occurrence of mouse 2-macroglobulin antigenic determinants on Schistosoma mansoni adults, with evidence on their nature. J Parasitol, 1973;59:64-73
30. Dean DA. Decreased binding of cytotoxic antibody by developing Schistosoma mansoni. Evidence for surface change independent of host antigen adsorption and membrane turnover. J Parasitol, 1977;63:418 -426
31. Butterworth AE. Human immunity to schistosomes: some questions. Parasitol Today, 1994;10:378-380
32. Hagan P, Blumenthal UJ, Dunn D, Simpson AJ, Wilkins HA. Human IgE, IgG4 and resistance to reinfection with Schistosoma haematobium. Nature, 1991;349:243-245
33. Woolhouse ME, Taylor P, Matanhire D, Chandiwana SK. Acquired immunity and epidemiology of Schistosoma haematobium. Nature, 1991;351:757-759
34. Warren KS, Schistosomiasis: past, present and future. Mem Inst Oswaldo Cruz, 1987;82(Suppl 4):25-29
35. Kojima S. Schistosmes: clinical and pathological aspects of infection. In: Microbiology and Microbial Infections (Topley and Wilson's, eds.). Ninth edition, published by Oxford University Press, Inc., New York, USA, 1998;5:479-505
36. Kojima S, Yokogawa M, Tada T. Raised levels of serum IgE in human helminthiases. Am J Trop Med Hyg, 1972;21:913-918
37. Nash TE, Cheever AW, Ottesen EA, Cook JA. Schistosome infections in humans: perspectives and recent findings. NIH conference. Ann Intern Med, 1982;97:740-754
38. Von Lichtenberg F, Sadun EH, Cheever AW, Erickson DG, Johnson AJ, Boyce HW. Experimental infection with Schistosoma japonicum in chimpanzees. Am J Trop Med Hyg, 1971;20:850-893
39. DeCock KM. Hepatosplenic schistosomiasis, a clinical review. Gut, 1986;27:734-745
40. Coutinho A. Hemodynamic studies of portal hypertension in schistosomiasis. Am J Med, 1968;44:547-556
41. Alves CA, Alves AR, Abreu WN, Andrade ZA. Hepatic artery hypertrophy and sinusoidal hypertension in advanced schistosomiasis. Gastroenterology, 1977;72:126-128
42. Sherlock S. Disease of the liver and biliary system. Eight edition. Blackwell Scientific puplications. Oxford, London, Edinburgh, 1989
43. Boyer TD. "Portal hypertension and its complications". In Hepatology (Zakim D, Boyer TD, eds.). Phildelphia, Saunders, 1982:464
44. Lebrec D, De Fleury P, Rueff B, Nahum H, Benhamou JP. Portal hypertension, size of esophageal varices, and risk of gastrointestinal bleeding in alcoholic cirrhosis. Gastroenterology, 1980;79:1139-1144
45. Anthony PP, Ishak KG, Nayak NC, Poulsen HE, Scheuer PJ, Sobin LH. The morphology of cirrhosis: definition, nomenclature, and classification. Bull World Health Organ, 1977;55:521-540
46. Cook GC. Intestinal schistosomiasis. In Tropical Gastroenterology. Oxford, Delhi, 1980:394
47. Mostafa MH, Sheweita SA, OConnor PJ. Relationship between schistosomiasis and bladder cancer. Clin Microbiol Rev, 1999;12:97 -111
48. Wright ED, Chiphangwi J, Hutt MS. Schistosomiasis of the female genital tract. A histopathological study of 176 cases from Malawi. Trans R Soc Trop Med Hyg, 1982;76:822-829
49. Feldmeier H, Poggensee G, Krantzl, Helling-Giese G. Female genital schistosomiasis. New challenges from a gender perspective. Trop Geogr Med, 1995;47(Suppl 2):S2-15
50. Feldmeier H, Krantz I, Poggensee G. Female genital schistosomiasis as a risk factor for transmission of HIV. Int J STD AIDS, 1994;5: 368-372
51. Warren KS, Domingo EO, Cowan RB. Granuloma formation around schistosome eggs as a manifestation of delayed hypersensitivity. Am J Pathol, 1967;51:735-756
52. Mosmann T, Coffman RL. Heterogenity of cytokine secretion patterns and function of helper T cells. Adv Immunol, 1989;46:111-147
53. Takatsu K, Takaki S, Hitoshi Y. Interleukin-5 and its receptor system: implications in the immune system and inflammation. Adv Immunol, 1994;57:145-190
54. Feldmeier H, Poggensee G. Diagnostic techniques in schistosomiasis control. A review. Acta Trop, 1993;52:205-220
55. Knight WB, Hiatt RA, Cline BL, Ritchie LS. A modification of the formolether concentration technique for increased sensitivity in detecting Schistosoma mansoni eggs. Am J Trop Med Hyg, 1976;25: 818-823
56. Komiya Y, Kobayashi A. Evaluation of Katós thick smear technic with a cellophane cover for helminth eggs in feces. Jpn J Med Sci Biol, 1966;19:59-64
57. Katz N, Chaves A, Pellegrino J. A simple device for quantitative stool thick-smear technique in Schistosomiasis mansoni. Rev Inst Med Trop Sao Paulo, 1972;14:397-400
58. Peters PA, El-Alamy M, Warren KS, Mahmoud AA. Quick Kato smear for field quantification of Schistosoma mansoni eggs. Am J Trop Med Hyg, 1980;29:217-219
59. Badran A, El-Alfi O, Pfischner WC, Killough JH, Burns TW. The value of routine rectal biopsy in the diagnosis of schistosomiasis. Am J Trop Med Hyg, 1955;4:1068-1071
60. Harries AD, Fryatt R, Walker J, Chiodini PL, Bryceson AD. Schistosomiasis in expatriates returning to Britain from the tropics: a controlled study. Lancet, 1986;1:86-88
61. Van Wijk HB. Schistosoma intercalctum, infection in school-children of bun camcroon. Trop Geogr Med, 1969;21:375-382
62. Farid Z. Schistosomes with terminal-spined egg: pathological and clinical aspects. In: Human schistosomiasis (Jordan P, Webbe G, Sturrock RF, eds.) Wallingford, UK: CAP International, 1993:159 -193
63. Homeida M, Abdel-Gadir AF, Cheever AW, Bennett JL, Arbab BM, Ibrahium SZ, Abdel-Salam IM, Dafalla AA, Nash TE. Diagnosis of pathologically confirmed Symmers' periportal fibrosis by ultrasonography: a prospective blinded study. Am J Trop Med Hyg, 1988;38:86-91
64. Feldmeier H, Stevens WJ, Bridts CH, Daffalla AA, Buttner DW. Effect of chemotherapy and reinfection on IgE-containing and IgG-containing circulating immune complexes, serum IgE and IgE antibodies in patients chronically infected with Schistosoma mansoni and Schistosoma haematobium. Int Arch Allergy Appl Immunol, 1983; 72:211-218
65. Burki A, Tanner M, Burnier E, Schweizer W, Meudt R, Degremont A. Comparison of ultrasonography, intravenous pyelography and cytoscopy in detection of urinary tract lesions due to S. hematobium. Acta Trop, 1986;43:139-151
66. Savioli L, Dixon H, Kisumku UM, Mott KE. Control of morbidity due to Schistosoma haematobium on Pemba island; selective population chemotherapy of school children with haematuria to identify high-risk localities. Trans R Soc Trop Med Hyg, 1989;83:805-810
67. Proietti FA, Antunes CM. Sensitivity, specificity and positive predictive value of selected clinical signs and symptoms associated with schistosomiasis mansoni. Int J Epidemiol, 1989;18:680-683
68. Hairston NG. The dynamics of transmission. In: epidemology and control of schistosomiasis (Ansari N, ed.). S. Karger, Basel, Munchen Paris London, 1973:261-333
69. Polman K, Stelma FF, Gryseels B, Van Dam GJ, Talla I, Niang M, Van Lieshout L, Deelder AM. Epidemiologic application of circulating antigen detection in a recent schistosoma mansoni focus in northern Senegal. Am J Trop Med Hyg, 1995;53:152-157
70. Cioli D, Pica-Mattoccia L, Archer S. Drug resistance in schistosomes. Parasitol Today, 1993;9:162-166
71. Davis A. Antischistosomal drugs and clinical practice. In human schistosomiasis (Jordan P, Webbe G, Sturrock RF, eds.). Wallingford, UK: CAP International, 1993:367-404
72. Andrews P, Thomas H, Pohlke R, Seubert J. Praziquantel. Med Res Rev, 1983;3:147-200
73. Becker B, Melhorn H, Andrews P, Thomas H, Ekert J. Light and electron microscopic studies on the effect of praziquantel on Schistosoma mansoni, Dicrocoelium dendriticum, and Fasciola hepatica (Trematoda) in vitro. Z Parasitenkd, 1980;63:113-128
74. Brindley PJ, Sher A. The chemotherapeutic effect of praziquantel against S. mansoni is dependent on host antibody response. J Immunol, 1987;139:215-220
75. Stelma FF, Talla I, Sow S, Kongs A, Niang M, Polman K, Deelder AM, Gryseels B. Efficacy and side effects of praziquantel in an epidemic focus of Schistosoma mansoni. Am J Trop Med Hyg, 1995; 53:167-170
76. Fallon PG, Fookes RE, Wharton GA. Temporal differences in praziquantel- and oxamniquine-induced tegumental damage to adult Schistosoma mansoni: implications for drug-antibody synergy. Parasitology, 1996;112(Pt 1):47-58
77. Ismail M, Metwally A, Farghaly A, Bruce J, Tao LF, Bennett JL. Characterization of isolates of Schistosoma mansoni from Egyptian villagers that tolerate high doses of praziquantel. Am J Trop Med Hyg, 1996;55:214-218
78. Davis A. Oxamniquine. In: Therapeutic drugs (Dollery C, ed.), volume 2, Churchill Livingstone, Edinburgh, 1991:42-45
79. El-Kouni MH. Chemotherapy of schistosomiasis. R I Med, 1992;75: 212-216